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Coxsackievirus Bl-induced murine myositis: no evidence for viral 
persistence
Jan Zoll,1* Peter Jongen,2 Jochem Galama,1 Frank van Kuppeveld1 and Willem Melchers1
Departments o f 1 Medical Microbiology and 2 Neurology, University o f Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, 
The Netherlands
The persistence of coxsackievirus B1 in the muscles of 
mice with coxsackievirus Bl-induced chronic myositis 
was investigated. Neonatal CD1 Swiss mice were 
inoculated with a myositis-causing variant of coxsackie­
virus B1 (Tucson strain). Hamstring muscle samples of 
diseased mice obtained at various times after inoculation 
were examined for the presence of infectious virus, viral 
RNA and histological abnormalities. Viral RNA was 
detected up to 4 weeks after initiation of infection, 
whereas virus could be isolated from hamstring muscles
for up to 2 weeks. Thereafter no sign of infection was 
demonstrated although histological abnormalities re­
mained present for the entire observation period of 16 
weeks. That viral RNA was detectable for only 2 weeks 
after tissues became negative for infectious virus suggests 
that the infection slowly waned rather than the viral 
RNA persisting. Hence, it is concluded that coxsackie­
virus B1 plays an essential role in the initiation of 
myositis but not in the maintenance of the chronic 
phase.
Introduction
Enteroviruses are thought to be involved in the de­
velopment of chronic diseases such as insulin-dependent 
diabetes mellitus, dilated cardiomyopathy, polymyositis/ 
dermatomyositis and post-viral fatigue syndrome. It 
has been suggested that these diseases are caused by an 
autoimmune reaction possibly triggered by a transient 
enteroviral infection (Dalakas, 1991; Woodruff, 1980). 
However, during the last decade, several papers have 
described the detection of enteroviral RNA in muscle 
tissues of patients suffering from dilated cardiomyopathy 
(Jin et al., 1990; Kandolf et al., 1987), polymyositis/ 
dermatomyositis (Bowles et al., 1987), and post-viral 
fatigue syndrome (Youssef et al., 1988), after the virus 
could no longer be isolated. They suggest that persistence 
of viral RNA might be involved in the pathogenesis of 
these diseases.
Several animal models have been developed, in which 
pancreatitis (Vella et al., 1992), cardiomyopathy (Gauntt 
et al., 1979) and myositis (Ray et al., 1979) are induced 
by infection with specific strains of coxsackie B viruses.
Ray et al. (1979) described a murine model for 
myositis induced by a coxsackievirus B1 infection of 
suckling mice. Studies with that model revealed evidence 
that immunological reactions cause the chronic myositis 
(Strongwater et al., 1984; Ytterberg, 1987). However, in 
recent studies using the same murine model it was found 
that although viral RNA was still present in affected 
muscle fibres no infectious virus could be isolated from
these samples (Tam et al., 1991). From this observation 
it was concluded that coxsackievirus B1 persisted after 
the acute phase of infection.
Recently, however, Koide et al. (1992) investigated the 
role of viral persistence during the development of 
murine cardiomyopathy. In this study the viral RNA 
could not be detected at more than 4 weeks after 
inoculation.
To investigate whether viral persistence indeed plays a 
pathogenic role in coxsackievirus Bl-induced myositis, 
we examined muscle samples from infected mice for the 
presence of infectious virus, viral RNA and histological 
abnormalities.
Methods
Virus strain. A myotropic coxsackievirus B1 strain (Tucson strain) 
causing myositis in CD1 Swiss mice was kindly provided by L. Minnich 
and G. Ray, University of Arizona, Tucson, Arizona, U.S.A. (Ray 
et al., 1979). The virus was propagated in buffalo green monkey kidney 
(BGM) cells and subsequently stored in aliquots at — 80 °C.
Animal model. Pregnant CD1 Swiss mice that were specific pathogen­
free and random-bred were purchased from Charles River Wiga. 
Neonates were randomly chosen from different litters and inoculated 
intraperitoneally within 24 h after birth with 1000 p.f.u. coxsackievirus 
B1 in 0-1 ml PBS (P. Jongen, unpublished results).
Infected mice were randomly divided among the mothers in groups 
of 10 to 14 animals. At 2 weeks post-inoculation (p.i.), infected mice 
were examined for clinical signs of myositis i.e. abnormal posture and 
a waddling gait. Animals appearing healthy at 2 weeks p.i. were 
excluded from further experiments. At 1, 2, 4, 8 and 16 weeks p.i., 
infected mice were sacrificed for histological and virological examin-
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Table 1. Semi-quantitative score for histological 
abnormalities in transverse sections o f hamstring 
muscles
Score
0 1 2 3 4
Infiltrating cells 0 <  10 10-50 50-100 > 100
Necrotic muscle 0 1-5 5-15 15-25 > 25
fibres
Central nuclei 0 <2 5 % 25-50% 50-75 % 75-100%
Atrophic muscle 0 <2 5 % 25-50% 50-75% 75-100%
fibres
ation. Gluteus, hamstring and quadriceps muscles from both hindlimbs 
were removed and divided into three equal parts each. For histological 
examination and in situ hybridization one part was placed in buffered 
formalin, paraffin-embedded and sectioned at 6 |xm. For PCR analysis 
examination one part was immediately frozen into liquid nitrogen 
and stored at — 80 °C until use. Another part was placed into 1 ml
of Hanks’ medium supplemented with 01%  yeast extract, 0-5% 
lactalbumin hydrolysate and 0-5% gelatin and stored at —80 °C until 
use for virus isolation.
Histological examination. From every muscle sample transverse 
sections were stained with haematoxylin-phloxin-saffron and ex­
amined using a light microscope (magnification x 250). Sections were 
read under code. Degrees of mononuclear cell infiltration, necrosis, 
central nuclei and muscle fibre atrophy were scored using a five-grade 
scale (Table 1).
In situ hybridization. Deparaffinized muscle sections were hybridized 
as described (Kandolf et al., 1987). Briefly, before hybridization the 
slides were treated with 0-2 m-HCI for 20 min, 2 x SSC at 70 °C for 
30 min, 20 mM-Tris-HCl pH 7-4, 2 mM-CaCl2 and 1 |tg/ml proteinase 
K at 37 °C for 15 min. Slides were washed in distilled water and 
dehydrated.
An infectious coxsackievirus B1 cDNA clone (kindly provided by 
Dr A. Nomoto, University of Tokyo, Japan) (Iizuka et al., 1991) was 
digested with Sal I. A 7-5 kb fragment representing the entire 
coxsackievirus B1 genome was purified by agarose gel electrophoresis 
and subsequently labelled with [a-35S]dCTP by nick-translation 
(Sambrook et al., 1989). Radiolabelled DNA fragments of 100 to 
400 bp were generated. Hybridization was performed using a mixture














1 1 + 1082 4 4 3 1
2 + 1040 4 4 3 2
3 + 1040 4 2 2 1
4 + 106'5 4 3 1 1
5 + l06-5 4 4 3 2
2 1 + — 4 4 3 3
2 + 1Q2-7 4 4 4 —
3 + — 3 4 2 2
4 + 1010 4 4 3 2
5 + 1020 4 4 2 3
4 1 + — 2 1 1 0
2 + — 2 2 2 3
3 + - 3 2 2 2
4 + — 3 4 2 1
5 + — 3 3 2 3
6 + — 4 4 2 2
7 + — 3 3 2 1
8 + — 1 0 1 0
9 + — 1 1 3 2
10 + - 4 4 2 2
8 1 — — 1 1 2 2
2 — — 2 1 1 2
3 - — 1 1 1 1
4 — — 2 1 2 2
5 — — 2 1 1 1
6 — — 2 1 1 1
7 - - 1 1 3 3
8 - - 3 2 2 2
9 — — 2 1 3 3
10 - - 3 4 3 2
16 1 - — 1 1 1 1
2 — — 2 2 1 1
3 — — 2 I 1 1
4 — — 1 1 2 1
5 - - 2 2 1 1
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Fig. 1. Hamstring muscle. Haematoxylin-phloxin staining, (a) Massive infiltration of mononuclear cells (centre), muscle fibre atrophy, 
necrotic fibres and loss of fibre 2 weeks p.i. Bar represents 100 nm. (b) Numerous mononuclear cells surrounding and partially invading 
necrotic muscle fibres 4 weeks p.i. Bar represents 50 |tm. (c) Endomysial infiltrate of mononuclear cells 8 weeks p.i. Bar represents 
50 (tm. (d) Muscle fibres with internal nuclei, fat cell replacement and sporadic myophagia, reflecting ongoing myopathy 16 weeks p.i. 
Bar represents 100 |im.
containing 200 ng/ml denatured 35S-labelled DNA probe in 10 mM- 
Tris-HCl pH 7-4, 50% (v/v) formamide, 0-6M-NaCl, 1 mM-EDTA, 
0-02% polyvinylpyrrolidone, 0-02% Ficoll, 0-05% BSA, 10% dextran 
sulphate, 10 mM-DTT, 200 ng/ml salmon sperm DNA and 100 ng/ml 
rabbit liver tRNA. After incubation at 25 °C for 36 h slides were 
washed at 30 °C for 18 h in 10 mM-Tris-HCl pH 7-4, 2 x SSC, 50% 
formamide and 1 mM-EDTA followed by 2 x SSC at 55 °C for 1 h. 
Hybridized muscle preparations were autoradiographed as described 
(Kandolf et al., 1987) and Giemsa-stained.
PCR. RNA was extracted from muscle samples using a single 
extraction with guanidinium thiocyanate-phenol-chloroform accord­
ing to the method of Chomczynski & Sacchi (1987). Reverse 
transcriptase reactions and PCR were performed according to Zoll et 
al. (1992). Briefly, cDNA was synthesized in a 20 jj.1 reaction mixture 
containing 75 mM-KCl, 50 mM-Tris-HCl pH 8-3, 3 mM-MgCl2, 10 mM- 
DTT, 0-2 m i  (each) deoxynucleoside triphosphate (Boehringer Mann­
heim), 50 pmol of antisense oligonucleotide primer (5' ATTGTCACC 
ATAAGCAGCCA 3'), 5 units of avian myeloblastosis virus reverse 
transcriptase (Promega) and extracted RNA. After incubation at 37 °C 
for 60 min, 80 jil of the PCR mixture was added. The PCR mixture 
contained 50 mM-KCl, 10 mM-Tris-HCl pH 8-9,3-6 mM-MgCl2, 0-2 mM 
(each) deoxynucleoside triphosphate, 100 ug of BSA/ml, 80 pmol of 
sense oligonucleotide primer ( 5' TCCTCCGGCCCCTGAATGCG 3'), 
40 pmol of antisense oligonucleotide primer and 0-2 units of SuperTaq
DNA polymerase (HT Biotechnology). RNA-cDNA hybrids were 
denatured at 94 °C for 5 min. The amplification was performed in 40 
cycles consisting of denaturation for 1 min at 94 °C, primer annealing 
for 1 min at 42 °C and elongation for 2 min at 72 °C. The reactions 
were analysed by electrophoresis in 2 % agarose gels and Southern blot 
hybridization. A 32P-end-labelled oligonucleotide (5' AAACACGGA 
CACCCAAAGTA 3') was used as the internal probe (Zoll et al., 1992).
Virus isolation. Muscle samples were homogenized using sterile sand, 
suspended in 1 ml of Earle’s medium and titrated in 10-fold dilutions 
on BGM monolayers in triplicate in a volume of 100 1^ (Schmidt, 




Neonatal CD1 Swiss mice from 10 litters were intra- 
peritoneally inoculated with lOOOp.f.u. coxsackievirus 
B1 (Tucson strain) in 0-1 ml PBS. Within the first 2 weeks 
mortality was 40%, and morbidity, expressed as the 
percentage of surviving animals demonstrating abnormal
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The number of mononuclear infiltrating cells, necrotic 
fibres and atrophic fibres reached a maximum within the 
first 2 weeks p.i. At least until 16 weeks p.i. infiltrating 
cells, necrosis and atrophy can be seen. The maximum 
number of fibres with central nuclei is reached at 8 weeks 
p.i. Mice inoculated with PBS developed no histological 
abnormalities.
Fig. 2. In situ detection of coxsackievirus B1 RNA in sections from the 
hamstring muscles 1 week p.i.
( a )
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Fig. 3. Southern blot hybridization of coxsackievirus B1-specific 
products of RNA isolated from right hamstring muscle samples, (a) 
Four weeks p.i.; (b) 8 weeks p.i. Numbers indicate the different mice. 
Lanes indicated by + , muscle sample obtained from an infected mouse 
1 week p.i.; lanes indicated by —, muscle sample from an uninfected 
mouse; lanes D, coxsackievirus B1 cDNA clone; lanes R, coxsackie­
virus B1 (Tucson) RNA. Size markers are indicated on the left.
gait and posture, was 60%. Animals appearing healthy 
at 2 weeks p.i. were excluded from further experiments. 
As a control, mice from two different litters were 
inoculated with 01 ml PBS only. At each time point after 
inoculation five to 10 mice were sacrificed. Skeletal 
muscles from both hindlegs were removed for further 
histological and virological exmination.
Histological examination
Preliminary examination (P. Jongen, unpublished re­
sults) revealed that histological abnormalities were most 
extensive in the hamstring muscles. Therefore, hamstring 
muscles were used for further investigations. Table 2 
gives the histological score and representative photo­
graphs are shown in Fig. 1 (a to d).
Detection o f virus and viral RNA
Muscle sections obtained 1 week p.i. were hybridized 
with a 35S-labelled DNA probe. The viral infection 
displays a focal character as shown in Fig. 2. Viral RNA 
is present in single muscle fibres whereas neighbouring 
fibres are not affected. Hamstring muscles were examined 
by virus isolation and PCR (Table 2).
One week p.i. all hamstrings tested contained viable 
virus and viral RNA. Two weeks p.i. viral RNA was 
detected in all of five hamstring muscles tested. Three of 
these five samples also contained viable virus as shown 
by virus isolation. The mean log10 virus titre in these 
three muscles, however, was decreased from 5-6 to 1-2. 
Four weeks after inoculation all of 10 mice tested 
contained viral RNA in the hamstring muscles of one or 
both hindlegs whereas viable virus could no longer be 
isolated. Viral RNA was not detected in muscle more 
than 4 weeks p.i. Fig. 3 shows the hybridization results of 
PCR products for some muscle samples obtained at 4 
and 8 weeks p.i.
Discussion
Polymyositis is an inflammatory disease of the skeletal 
muscle. It is the most frequently acquired muscular 
disease in adults and has a chronic progressive character. 
The pathogenesis of polymyositis is not well understood. 
In general, it is regarded as an autoimmune disease, 
possibly induced by a preceding enteroviral infection. On 
the other hand, several papers have been published 
which describe the detection of enteroviral RNA in 
skeletal muscle of patients in the absence of infectious 
virus (Bowels et al., 1987). These findings suggest that the 
virus persists after the acute phase of infection and that 
the virus itself may actually contribute to the main­
tenance of disease. However, several other groups could 
not confirm that the viral RNA was indeed still present 
in the chronic stage of disease, and questioned the idea 
that persistence of enteroviruses played an aetiological 
role (P. Jongen, unpublished results; Leff et al., 1992).
We have used coxsackievirus Bl-induced murine 
myositis as a model to investigate whether enteroviral 
persistence might play a role in the pathogenesis of 
myositis. Histological findings clearly showed a myositis 
continuing for at least 16 weeks that resembled poly­
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myositis in man (Table 1, Fig. 1). In situ hybridization on 
affected hamstring muscle showed a focal distribution of 
the viral RNA, which is also described in human 
polymyositis (Bowles et al., 1987), and which is also 
found in viral murine myocarditis (Kandolf et al., 1987; 
Klingel et al., 1992). Infectious virus was isolated from 
the affected muscles until 14 days p.i. Beyond this time 
the virus can no longer be isolated, although viral RNA 
could still be detected by PCR up to 4 weeks p.i. These 
results are in agreement with Tam et al. (1991) who were 
also able to detect viral RNA up to about 31 days p.i. in 
this animal model. However, although histologically an 
ongoing myositis was found, viral RNA was no longer 
present beyond 4 weeks p.i. Thus, it appears that the 
maintenance of disease in this model is not associated 
with the persistence of enteroviral RNA. Until now most 
studies on persistence of picornaviruses in murine models 
revealed similar results. Using an encephalomyocarditis 
virus variant, Cronin et al. (1988) induced myositis in 
mice. Virus was isolated at high titres 1 week p.i., but 
only at low titre 2 weeks p.i. Viral RNA was detected in 
skeletal muscle up to 3 weeks and only sporadically as 
late as 4 weeks p.i. Koide et al. (1992) detected viral 
RNA in a murine model of coxsackievirus B3-induced 
myocarditis, up to day 28 p.i. They described a decreasing 
number of positive animals with time: at day 14 p.i. five 
of six animals, and at day 28 p.i. only two of six animals 
were found positive for viral RNA. Thereafter, the viral 
RNA could no longer be detected in myocardial cells. A 
similar observation was made by Klingel et al. (1992). 
They described an ongoing myocarditis in the same 
animal model. Although the virus could not be isolated 
later than 15 days p.i., the viral RNA was still detectable 
up to 30 days p.i. However, in the acute phase of disease 
13% of the myocardial cells were found to be infected, 
whereas in the chronic phase at day 30 p.i., only 0 01 % 
of the myocardial cells were found positive for enteroviral 
RNA.
In a previous study the sensitivity of the PCR was 
determined to be 100 genomic RNA molecules (Zoll et 
al., 1992). Although the presence of smaller amounts 
cannot be detected it seems unlikely that only a few RNA 
molecules persist in a limited amount of cells, in contrast 
with the more extensive necrosis observed after 4 weeks 
p.i. Thus, in the mouse models of myositis and 
myocarditis, the viral RNA can be detected for approxi­
mately 4 weeks p.i. Since virus can be isolated for 2 weeks 
p.i., it means that the virus ‘ persists ’ for only 2 additional 
weeks.
Enteroviruses cause a lytic infection. The lytic infection 
is controlled by the immune system which will become 
active within 5 to 7 days. For reasons which are not fully 
understood, the lytic infection can be limited to a chronic 
productive one with focal necrosis and expression of
viral antigens in both surviving and necrotic cells (Vella 
et a l, 1992). Therefore, it may be that the virus can be 
trapped in a few cells which do not immediately lyse, 
probably due to defective virus replication. Several 
reports have described an abnormal production of equal 
amounts of positive and negative strands of enteroviral 
RNA in patients with the post-viral fatigue syndrome as 
well as in coxsackievirus B3-induced myocarditis in the 
mouse (Cunningham et al., 1990; Klingel et al., 1992). 
The presence of a 1:1 molar ratio of the plus- and minus­
strand RNA suggests the remaining presence of highly 
stabilized dsRNA intermediates which resist RNA 
degradation. The RNA will eventually be eliminated. 
Presumably this is what occurs in the murine after 
approximately 4 weeks. This means that the infection is 
waning.
Ytterberg and coworkers studied the murine myositis 
model extensively, especially the role of T cell activity 
(Ytterberg et al., 1987, 1988). These studies revealed that 
active virus and T cell activity were essential for the 
development of myositis. Mice with T cell deficiency, 
such as nude and athymic mice, did not develop myositis. 
This suggests that a chronic myositis may be caused by 
an immunologically mediated mechanism. In fact, a 
striking feature of all these different animal models is the 
necessity for infectious virus, and in most cases T cell 
activity, to induce a chronic inflammation. The inflam­
mation is demonstrated by histological parameters such 
as mononuclear infiltrating cells, necrosis, atrophy, etc. 
Histological abnormalities are visible in affected muscles 
for several months. However in this model, numbers of 
mononuclear infiltrates decrease with time indicating 
that the duration of the virus-induced chronic myositis is 
limited. Non-progressive gait abnormality observed 
several months after infection may be caused by the 
inflammation and corresponding loss of muscle tissue 
during the first 2 weeks of the infection. The presence of 
mononuclear infiltrating cells at 16 weeks p.i. indicates 
that the myositis is still occurring at this time.
Post-infectious autoimmunity has been postulated by 
many investigators and remains an important issue to be 
studied (Craighead et al., 1990). From studies in the 
murine cardiomyositis model it became clear that anti­
heart antibody is generated in the myocarditic mouse 
(Paque & Miller, 1991), and that autoreactive cytotoxic 
T lymphocytes are generated, which can cause cardiac 
damage after adoptive transfer to uninfected mice 
(Loudon et al., 1991). In addition, several epitopes have 
been described that show cross-reactivity between cox­
sackie B viruses and cardiac myosites (Paque & Miller, 
1991). The strain of coxsackie B virus used, as well as 
genetic factors of the host, are found to be of crucial 
importance. What makes a strain myocarditic or not is 
still poorly understood. The difference might reside in the
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type of immune response mounted against the various 
strains (Chow et al., 1991). It is exciting to speculate that 
molecular characteristics of the virus are involved in the 
immunopathology.
Although the viral infection appears to be essential for 
the initiation of inflammation (Ytterberg, 1987), a 
permanent presence of the viral RNA does not contribute 
to the maintenance of the disease.
We are indebted to Professor Dr R. Kandolf for his advice in the in 
situ hybridization technique. This study was supported by the Prinses 
Beatrix Fonds, The Netherlands (grants 89-2999 and 90-3137).
References
Bowles, N. E., Sewry, C. A., Dubowitz, V. & A rch ard , L. C. 
(1987). Dermatomyositis, polymyositis, and Coxsackie B virus 
infection. Lancet i, 1004-1007.
Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA 
isolation by acid guanidinium thiocyanate-phenol-chloroform ex­
traction. Analytical Biochemistry 162, 156-159.
Chow, L. H., G au n tt, C. J. & McManus, B. M. (1991). Differential 
effects of myocarditic variants of Coxsackievirus B3 in inbred mice. 
Laboratory Investigation 64, 55-64.
Craighead, J. E., Huber, S. A. & Shiram, S. (1990). Biology of 
disease. Animal models of picornavirus-induced autoimmune dis­
ease : their possible relevance to human disease. Laboratory Investig­
ation 63, 432-446.
Cronin, M. E., Love, L. A., M ille r, F. W., M cC lin tock, P. R. & 
P lo tz , P. H. (1988). The natural history of encephalomyocarditis 
virus-induced myositis and myocarditis in mice. Journal o f Ex­
perimental Medicine 168, 1639-1648.
Cunningham, L., Bowles, N. E., Lane, R. J. M., Dubowitz, V. & 
A rch ard , L. C. (1990). Persistence of enteroviral RNA in chronic 
fatigue syndrome is associated with the abnormal production of 
equal amounts of positive and negative strands of enteroviral RNA. 
Journal o f General Virology 71, 1399-1402.
D alakas, M. C. (1991). Polymyositis, dermatomyositis, and inclusion- 
body myositis. New England Journal o f Medicine 325, 1487-1498.
G au n tt, C. J., T rousdale, M. D., LaBadie, D. R. L., Paque, R. E. & 
N ealon, T. (1979). Properties of Coxsackievirus B3 variants which 
are amyocarditic or myocarditic for mice. Journal o f Medical 
Virology 3, 207-220.
Iizuka, N., Yonekawa, H. & Nomoto, A. (1991). Nucleotide 
sequences important for translation initiation of enterovirus RNA. 
Journal o f Virology 65, 4867—4873.
Jin, O., Sole, M. J., Butany, J. W., Chia, W., M cLaughlin, P. R., 
Lia, P. & Liew, C. (1990). Detection of enterovirus RNA in 
myocardial biopsies from patients with myocarditis and cardio­
myopathy using gene amplification by polymerase chain reaction. 
Circulation 82, 8-16.
K andolf, R., Ameis, D., K irschner, P., Canu, A. & Hofschneider, 
P. H. (1987). In situ detection of enteroviral genomes in myocardial 
cells by nucleic acid hybridization: an approach to the diagnosis of 
viral heart disease. Proceedings o f the National Academy o f Sciences, 
U.S.A. 84, 6272-6276.
Klingel, K., Hohenadl, C., Canu, A., Albrecht, M., Seemann, M., 
Mall, G. & Kandolf, R. (1992). Ongoing enterovirus-induced
myocarditis: quantitative analysis of virus replication, tissue damage, 
and inflammation. Proceedings o f the National Academy o f Sciences, 
U.S.A. 89, 314-318.
Koide, H., K itau ra , Y., Deguchi, H., Ukimura, A., Kawam ura, K. 
& Hirai, K. (1992). Viral genomic detection in the heart of C3H/He 
mice with experimental Coxsackievirus B3 myocarditis by gene 
amplification using the polymerase chain reaction. Japanese Journal 
o f Circulation 56, 148-156.
Leff, R. L., Love, L. A., M ille r, F. W., G reenberg, S. J., K lein, 
E. A., D alakas, M. C. & P lo tz , P. H. (1992). Viruses in idiopathic 
inflammatory myopathies: absence of candidate viral genomes in 
muscle. Lancet 339, 1192-1195.
Loudon, R. P., M oraka, A. F., Huber, S. A., Schwimmbeck, P. & 
Schultheiss, P. (1991). An attenuated variant of Coxsackievirus B3 
preferentially induces immunoregulatory T cells in vivo. Journal o f 
Virology 65, 5813-5819.
Paque, R. E. & M ille r, R. (1991). Auto anti-idiotypes exhibit mimicry 
of myocyte antigens in virus induced myocarditis. Journal o f Virology 
65, 16-22.
Ray, C. G., Minnich, L. L. & Johnson, P. C. (1979). Selective 
polymyositis induced by Coxsackievirus B1 in mice. Journal o f 
Infectious Diseases 140, 239-243.
Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty 
percent endpoints. American Journal o f Hygiene 27, 493^197.
Sambrook, J., F ritsch , E. F. & M aniatis, T. (1989). Molecular 
Cloning: A Laboratory Manual, 2nd edn., New York: Cold Spring 
Harbor Laboratory.
Schmidt, N. J. (1979). Cell culture techniques for diagnostic virology. 
In Diagnostic Procedures for Viral, Rickettsial and Chlamydial 
Infections, pp. 65-139. Edited by E. H. Lennette & N. J. Schmidt. 
Washington, D .C .: American Public Health Association.
S trongw ater, S. L., Dorovini-Zis, K., B a ll, R. D. & Schnitzer, T. 
J. (1984). A murine model of polymyositis induced by Coxsackievirus 
B1 (Tucson strain). Arthritis and Rheumatism 27, 433^42.
Tam, P. E., Schmidt, A. M., Y tte rberg , S. R. & Messner, R. P. 
(1991). Viral persistence during the developmental phase of Cox­
sackievirus Bl-induced murine polymyositis. Journal o f Virology 65, 
6654-6660.
V ella, C., Brown, C. L. & M cC arthy , D. A. (1992). Coxsackievirus 
B4 infection of the mouse pancreas: acute and persistent infection. 
Journal o f General Virology 73, 1387-1394.
W oodruff, J. F. (1980). Viral myocarditis. American Journal o f 
Pathology 101, 425-483.
Yousef, G. E., B ell, E. J., M ann, G. F., M urugesan, V., Smith, 
D. G., M cC artney, R. A. & Mowbray, J. F. (1988). Chronic 
enterovirus infection in patients with postviral fatigue syndrome. 
Lancet i, 146-149.
Y tterberg , S. R. (1987). Coxsackievirus B1 induced murine poly­
myositis : acute infection with active virus is required for myositis. 
Journal o f Rheumatology 14, 12-18.
Y tterberg , S. R., M ahow ald, M. L. & Mesner, R. P. (1987). 
Coxsackievirus Bl-induced polymyositis; lack of disease expression 
in nu/nu mice. Journal o f Clinical Investigations 80, 499-506.
Y tte rberg , S. R., M ahow ald, M. L. & Messner, R. P. (1988). T-cells 
are required for Coxsackievirus B1 induced murine polymyositis. 
Journal o f Rheumatology 15, 475—478.
Z o ll, G. J., M elchers, W. J. G., Kopecka, H., Jambroes, G., van der 
Poel, H. J. A. & Galama, J. M. D. (1992). General primer-mediated 
polymerase chain reaction for detection of enteroviruses; application 
for diagnostic routine and persistent infections. Journal o f Clinical 
Microbiology 30, 160-165.
{Received 11 March 1993; Accepted 11 June 1993)
